Skip to content
clinical trials latin america
  • Sites and Network
Menu
  • Sites and Network
  • Español
Linkedin Twitter Facebook-f Youtube
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Insights
    • Our Science
    • News
  • Contact
Menu
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Insights
    • Our Science
    • News
  • Contact
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About Cohortias
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Insights
    • News
    • Our Science
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Contact
  • Ir a sitio en español
Menu
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About Cohortias
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Insights
    • News
    • Our Science
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Contact
  • Ir a sitio en español

Author: quickappsmkt

This author has written 338 articles
  1. Home>
  2. quickappsmkt>
  3. Page 5
Read more about the article First-in-Human – Treatment of Merkel Cell Carcinoma.
Merkel

First-in-Human – Treatment of Merkel Cell Carcinoma.

  • Post author:quickappsmkt
  • Post published:February 8, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

Phase 1 clinical study evaluating ITI-3000 in patients with Merkel cell carcinoma.

Continue ReadingFirst-in-Human – Treatment of Merkel Cell Carcinoma.
Read more about the article Clinical Trial – Phase 2b/3 for prurigo nodularis treatment.
prurigo nodularis

Clinical Trial – Phase 2b/3 for prurigo nodularis treatment.

  • Post author:quickappsmkt
  • Post published:February 3, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The company anticipates reporting top-line results in the second quarter of this year.

Continue ReadingClinical Trial – Phase 2b/3 for prurigo nodularis treatment.
Read more about the article First-in-Human – Phase 3 for new Schizophrenia treatment.
Schizophrenia

First-in-Human – Phase 3 for new Schizophrenia treatment.

  • Post author:quickappsmkt
  • Post published:February 1, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

Reviva anticipates expanding the clinical development of brilaroxazine into other neuropsychiatric indications.

Continue ReadingFirst-in-Human – Phase 3 for new Schizophrenia treatment.
Read more about the article Clinical Trials – Moderna HIV vaccine candidate.
Moderna

Clinical Trials – Moderna HIV vaccine candidate.

  • Post author:quickappsmkt
  • Post published:January 31, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The vaccine was designed to prompt white blood cells turn into antibodies that could neutralize HIV.

Continue ReadingClinical Trials – Moderna HIV vaccine candidate.
Read more about the article Clinical Trial – Phase II autism spectrum disorder trial.
autism spectrum disorder

Clinical Trial – Phase II autism spectrum disorder trial.

  • Post author:quickappsmkt
  • Post published:January 28, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The multicentre, randomized trial of L1-79 will enroll nearly 50 subjects of the age 12 to 21 years.

Continue ReadingClinical Trial – Phase II autism spectrum disorder trial.
Read more about the article Clinical Trials – Pancreatic adenocarcinoma treatment.
Pancreatic adenocarcinoma

Clinical Trials – Pancreatic adenocarcinoma treatment.

  • Post author:quickappsmkt
  • Post published:January 27, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

Screening for eligible subjects for the trial has started and enrollment is anticipated to conclude in nearly one year.

Continue ReadingClinical Trials – Pancreatic adenocarcinoma treatment.
Read more about the article First-in-Human – Treatment for Advanced Liver Cancer.
liver cancer

First-in-Human – Treatment for Advanced Liver Cancer.

  • Post author:quickappsmkt
  • Post published:January 25, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

OUTREACH-2 study evaluating MTL-CEBPA in combination with sorafenib in up to 150 patients.

Continue ReadingFirst-in-Human – Treatment for Advanced Liver Cancer.
Read more about the article Clinical Trial – Chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease

Clinical Trial – Chronic obstructive pulmonary disease.

  • Post author:quickappsmkt
  • Post published:January 24, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

Ensifentrine is a first-in-class product candidate that combines bronchodilator and anti-inflammatory activities in one compound.

Continue ReadingClinical Trial – Chronic obstructive pulmonary disease.
Read more about the article Clinical Trial – Phase IIb of atopic dermatitis antibody.
atopic dermatitis

Clinical Trial – Phase IIb of atopic dermatitis antibody.

  • Post author:quickappsmkt
  • Post published:January 21, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The trial is expected to enrol subjects across 100 sites in North America, Asia Pacific and Europe.

Continue ReadingClinical Trial – Phase IIb of atopic dermatitis antibody.
Read more about the article First-in-Patient – New Treatment of Parkinson’s Disease.
parkinsons

First-in-Patient – New Treatment of Parkinson’s Disease.

  • Post author:quickappsmkt
  • Post published:January 20, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

In preclinical studies, NE3107 was shown to improve motor symptoms as effectively as L-dopa.

Continue ReadingFirst-in-Patient – New Treatment of Parkinson’s Disease.
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 34
  • Go to the next page

Direct Contact

[email protected]
covid clinical trials
  • [email protected]
  • +52 81 2719 3064
  • C. Del Comercio 565, SPGG, N.L. México.
  • Privacy Policy

Solutions

  • Full Service CRO
  • Research & Development
  • Study Design
  • Sites Activation
  • Protocol Writing

Company

  • Cohortias Core
  • Background
  • Locations
  • Team Members
  • Opportunities

get started

  • Know Latin America
  • Standard-of-care
  • Regulatory Infrastructure
  • Cases & Evidence
  • Resources

Quarterly Newsletter

Cohortias International © All rights reserved

Linkedin Twitter Facebook-f Youtube